glp-1 and kidney disease receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal Glucagon-like Peptide-1 Receptor Agonists: New

TsokoMBeauseigneurFGrestiJNiotIDemarquoyJBoichotJet al

While many factors influence long-term health, healthy glutathione levels are widely recognised as an important component of overall wellbeing and cellular health

However, these peptide-based biologics are complex and costly to make, requiring specialized facilities and lengthy scale-up timelines

The potential functions of tocochromanol catabolites are under active investigation because they retain their antioxidant activity and are more water soluble than the parent compounds

Our goal here is simply to keep potassium levels balanced (or greater) than those of sodium